{{Rsnum
|rsid=3095318
|Gene=CDSN
|Chromosome=6
|position=31088145
|Orientation=minus
|GMAF=0.1172
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|Gene_s=CDSN,PSORS1C1
}}
{{PharmGKB
|RSID=rs3095318
|Name_s=
|Gene_s=PSORS1C1, CDSN, C6orf15
|Feature=
|Evidence=PubMed ID:16998491
|Annotation=Risk or phenotype-associated allele: allele 1. Phenotype: Tagging SNP for HLA-B*5801. Study size: 44. Study population/ethnicity: Japanese from Tokyo, Japan. Significance metric(s): Type of association: GN
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291981
}}

{{PMID|16642438|OA=1
}} Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.

{{GET Evidence
|gene=CDSN
|aa_change=Met18Leu
|aa_change_short=M18L
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3095318
|overall_frequency_n=2020
|overall_frequency_d=10730
|overall_frequency=0.188257
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|nblosum100=-3
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}